Best candidates for tirzepatide Tirzepatide is the stronger choice for researchers who: Want a proven, FDA-approved compound with extensive safety data Need reliable, consistent access through established supply chains Prefer multiple administration options (injectable, oral drops , tablets ) Have lower side effect tolerance and want a more predictable GI experience Are achieving satisfactory weight loss goals (15-22% range) Want insurance coverage possibilities Are new to GLP-1 agonist therapy and want to start with the established option Need to travel with their medication and want pharmacy accessibility The practical advantages of tirzepatide cannot be overstated for many researchers
Oral supplementation is not as effective as intravenous administration because the supplements go through the digestive system, reducing their bioavailability
When combined with a GLP-1 receptor agonist, this may result in greater improvements in blood glucose and body weight
That does not mean every GLP-1 user will have a bad experience
10 Ongoing trials are currently studying semaglutide and tirzepatide for alcohol use disorder, semaglutide for opioid use and cannabis use disorder, liraglutide for opioid use disorder, and semaglutide and exenatide to achieve smoking cessation